References
- Mauch P. M. Controversies in the management of early stage Hodgkin's disease. Blood 1994; 83: 318–29
- Cosset J., Henry-Amar M., Meerwaldt J. Long-term toxicity of early stages of Hodgkin's disease therapy: The EORTC experience. Ann Oncot 1991; 2: 77–82
- Lobato-Mendirábal E., Ruiz-Argüelles G. J. Problenias en el tratamiento de las hemopatías malignas en Iberoamérica. Enciclopedia Iberoamericana de Hematología, A. López-Borrasca, C. L. Arocha-Piftango, C. Campos-, C Guerra, A. Parreira, S. Pavlovsky, G. J. Ruiz-Arguelles, J. F. San-Miguel. Ediciones Universidad de Salamanca, SalamancaSpain 1992; IV-662–IV-666
- Longo D. L., Banks P. M., Hoppe R. T. Hodgkin's disease. Rev Invest Clín Méx 1994; 46(Suppl 1)73–83
- Pavlovsky S., Maschio M., Santarelli M., Muriel F., Corrado C., Garcia I., Schwartz L., Montero C. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-11 Hodgkin's disease. J Natl Cancer. Inst 1988; 80: 1466–70
- Connors J. M., Klimo P. MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease. Sem Hematol 1987; 24: 35–40
- Carbone P. P., Kaplan H. S., Musshof K., Sniithers D. W., Tubiana M. Report of the committee on Hodgkin's disease staging. Cancer Res 1971; 31: 1860–1861
- Reverter J. C., Montserrat E. Detection of abdominal involvement in Hodgkin's disease: Is there still a role for staging laparotomy?. Hematol Rev 1994; 8: 273–286
- Ruiz-Argüelles G. J., Ruiz-Argüelles A., Pérez-Romano B., Marín-López A., Larregina-Díez A., Apreza-Molina M. G. Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy. Am J Hematol 1995; 48: 100–103
- Avilés A., Yañez A., López T., García E. L., Guzmán R., Díaz-Maqueo J. C. Malnutrition as an adverse prognostic factor in patients with diffuse large cell lymphoma. Arch Med Res 1995; 26: 31–34
- Lobato-Mendizábal E., Ruiz-Argüelles G. J., Marín-López A. Leukaemia and nutrition I. Malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard-risk acute lymphoblastic leukaemia. Leuk Res 1989; 13: 899–906
- Gómez-Almaguer D., Montemayor J., Gonzàlez-Llano O., Ruiz-Argüelles G. J., Betz N. L., Marfil-Rivera J. Leukemia and nutrition IV. Improvement in the nutritional status of children with standard-risk acute lymphoblastic leukemia is associated with better tolerance of continuation chemotherapy. Int J Ped Hem Oncol 1995; 2: 53–56
- Ruiz-Argüelles G. J., Apreza-Molina M. G., Alemán-Hoey D. D., Gómez-Almaguer D., Marín-Lólpez A., Mercado-Díaz L. Outpatient supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia (AML) is feasible: A multicentre study. Eur J Haematol 1995; 54: 18–20
- Ruiz-Argüelles G. J., Ruiz-Reyes G. El tratamiento de las leucemias en países en desarrollo: El caso de México. Actualización en leucemias, G J Ruiz-Argüelles, J F. San-Miguel. Editorial Médica Panamericana. 1996; 147–151
- Romero-García F., Delgado-Lamas J. L., Rodríguez-Carrillo J., Vázquez-Villegas V. Enfermedad de Hodgkin. Rev Invest Clin Méx 1995; 47(Suppl 1)32–38
- Bladé J., Reverter J. C. Postsplenectomy sepsis in Hodgkin's disease: Assesment of the risk and clinical approach. Hematol Rev 1994; 8: 287–294
- Donaldson S. S., Hancock S. L. Second cancers after Hodgkin's disease in childhood. N Engl J Med 1996; 334: 192–194
- Tucker M., Coleman C., Cox R., Varghese A., Rosenberg S. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988; 318: 76–81